Burgess Justin 4

4 · DYNAVAX TECHNOLOGIES CORP · Filed Feb 20, 2024

Form 4

Period: 2024-02-15

VP Finance & CAO

Transactions

Exercise/Conversion
Common Stock
2024-02-16+6,667→ 15,803 total
Tax Payment
Common Stock
2024-02-16$12.41/sh−2,378$29,511→ 13,425 total
Exercise/Conversion
Restricted Stock Unit
2024-02-16−6,667→ 13,333 total
→ Common Stock (6,667 underlying)
Award
Stock Options (Right to Buy)
2024-02-15+13,500→ 13,500 total
Exercise: $12.48Exp: 2031-02-15→ Common Stock (13,500 underlying)
Award
Restricted Stock Unit
2024-02-15+21,900→ 21,900 total
→ Common Stock (21,900 underlying)

Footnotes (7)

[F1]Code M: Exercise or conversion of derivative security
[F2]Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 16, 2023.
[F3]Code F: Payment of exercise price or tax liability by delivering or withholding securities
[F4]Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.
[F5]Code A: Grant, award or other acquisition
[F6]This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 15, 2024, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
[F7]Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.

Documents

1 file